IP Library Granted Patent US 9,328,351
Granted Patent B2
US 9,328,351 · App. 13/688,025 · Granted May 3, 2016

Genetically engineered microbial strains including

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,328,351
App. No.
13/688,025
Granted
May 3, 2016
Kind
B2
Abstract

Genetically engineered microbial, e.g., Prototheca , cells provide microbial oil useful as a food additive and a source of renewable fuels and industrial chemicals.

Claims (13)

1. A recombinant nucleic acid comprising a coding sequence that encodes a Prototheca lipid droplet protein 1 having at least 95% sequence identity with SEQ ID NO: 120, wherein the coding sequence is operably linked to an exogenous nucleic acid sequence.

2. The recombinant nucleic acid of claim 1 , wherein the protein has at least one amino acid substitution in comparison to SEQ ID NO: 120.

3. The recombinant nucleic acid of claim 1 , wherein the exogenous nucleic acid sequence comprises a promoter.

4. The recombinant nucleic acid of claim 1 , wherein the exogenous nucleic acid sequence comprises an untranslated control element.

5. The recombinant nucleic acid of claim 1 , wherein the exogenous nucleic acid sequence encodes a targeting sequence.

6. The recombinant nucleic acid of claim 5 , wherein the targeting sequence is a transit peptide selected from the group of a plastidial targeting sequence and a mitochondrial targeting sequence.

7. The recombinant nucleic acid of claim 1 , wherein the nucleic acid is a DNA molecule.

8. The recombinant nucleic acid of claim 1 that encodes a functional Prototheca LPD1.

9. The recombinant nucleic acid of claim 1 that further encodes a sucrose invertase.

10. The recombinant nucleic acid of claim 1 that further encodes an inhibitory RNA that suppresses expression of a Prototheca lipid biosynthesis gene.

11. An expression cassette comprising a recombinant nucleic acid of claim 1 .

12. A genetically engineered microbial cell transformed with a recombinant nucleic acid of claim 1 .

13. A method for obtaining microbial oil comprising culturing a genetically engineered Prototheca cell of claim 12 under conditions such that oil is produced.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2017
From: TERRAVIA HOLDINGS, INC.
To: CORBION BIOTECH, INC.
Reel/Frame 044424/0211 →
CHANGE OF NAME Recorded May 23, 2016
From: SOLAZYME, INC.
To: TERRAVIA HOLDINGS, INC.
Reel/Frame 038794/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: FRANKLIN, SCOTT; BRUBAKER, SHANE; RUDENKO, GEORGE N.; ZHAO, XINHUA; MOSELEY, JEFFREY L.; HUYNH, TINA T.; BHAT, RIYAZ; SHOA-AZAR, MATTHEW; NGUYEN, TRUNG H.; ESPINA, KAREN; SOMANCHI, ARAVIND
To: SOLAZYME, INC.
Reel/Frame 030176/0894 →